Eli Lilly will significantly increase the price of its weight-loss drug Mounjaro in the United Kingdom in a bid to bring down ...

Eli Lilly has temporarily paused shipments of its weight-loss drug Mounjaro in the UK, ahead of a new price hike for the ...

The statement appears to be a response to the President’s recent publication of letters to 17 pharma companies about reducing drug prices.

Ahead of plans to raise the price of its Type 2 diabetes and obesity blockbuster in the U.K. next month, Eli Lilly is temporarily halting Mounjaro orders from the country. | Ahead of plans to raise ...

On Thursday, Eli Lilly and Co. (NYSE:LLY) said it will sharply increase the list price of its weight-loss ... meaningfully ...

Eli Lilly's orforglipron could have a few advantages over a pill from Novo Nordisk, including a lack of dietary restrictions ...

Eli Lilly said the increase brings the UK price in line with other European markets, though NHS availability will be ...

The company says broad tariffs would raise costs, limit patient access and undermine domestic manufacturing. Eli Lilly is sounding a warning on proposed tariffs on pharmaceuticals, saying it would ...

On August 26, 2025, Eli Lilly announced positive topline results from its Phase 3 ATTAIN-2 trial of orforglipron, an ...

Eli Lilly and Company (NYSE:LLY) is included in our list of the 11 Best Rebound Stocks to Buy According to Hedge Funds. On August 8, 2025, JPMorgan maintained its ‘Overweight’ rating on Eli Lilly and ...